Identification of F5 as a Prognostic Biomarker in Patients With Gastric Cancer

BioMed Research International - United States
doi 10.1155/2020/9280841
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Identification of a Three miRNA Signature as a Novel Potential Prognostic Biomarker in Patients With Blaader Cancer

Oncotarget
Oncology
2017English

Conversion Surgery in Metastatic Gastric Cancer and Cancer Dormancy as a Prognostic Biomarker

Cancers
Cancer ResearchOncology
2019English

Plasma microRNA Profiles: Identification of miR-1229-3p as a Novel Chemoresistant and Prognostic Biomarker in Gastric Cancer

Scientific Reports
Multidisciplinary
2020English

Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

MDM2 Is a Useful Prognostic Biomarker for Resectable Gastric Cancer

Cancer Science
Cancer ResearchMedicineOncology
2013English

PD-L1 Expression Combined With Microsatellite Instability/Cd8+ Tumor Infiltrating Lymphocytes as a Useful Prognostic Biomarker in Gastric Cancer

Scientific Reports
Multidisciplinary
2019English

Differentially Expressed lncRNAs in Gastric Cancer Patients: A Potential Biomarker for Gastric Cancer Prognosis

Journal of Cancer
Oncology
2017English

The CD4+/CD14+HLA-DRlo/neg Ratio as a Prognostic Biomarker in Cancer Patients

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Disseminated Tumour Cells as a Prognostic Biomarker in Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy